Illumina (0J8Z) Share Forecast & Price Target

1 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0J8Z Analyst Ratings

Moderate Buy

8 Buy

5 Hold

3 Sell

Based on 16 analysts giving stock ratings to

Illumina

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0J8Z Stock 12 Month Forecast

Average Price Target

$197.44

▼(-12.30% Downside)

Based on 16 Wall Street analysts offering 12 month price targets for Illumina in the last 3 months. The average price target is $197.44 with a high forecast of $235.00 and a low forecast of $113.00. The average price target represents a -12.30% change from the last price of $225.14.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"98":"$98","167":"$167","236":"$236","132.5":"$132.5","201.5":"$201.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":235,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$235.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":197.4375,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$197.44</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":113,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$113.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[98,132.5,167,201.5,236],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,208.56,210.59384615384616,212.6276923076923,214.66153846153847,216.69538461538463,218.72923076923078,220.76307692307694,222.79692307692306,224.83076923076922,226.86461538461538,228.89846153846153,230.9323076923077,232.96615384615384,{"y":235,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,208.56,207.7044230769231,206.84884615384615,205.99326923076924,205.1376923076923,204.2821153846154,203.42653846153846,202.57096153846155,201.7153846153846,200.8598076923077,200.00423076923076,199.14865384615385,198.2930769230769,{"y":197.4375,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,208.56,201.20923076923077,193.85846153846154,186.5076923076923,179.15692307692308,171.80615384615385,164.45538461538462,157.10461538461539,149.75384615384615,142.40307692307692,135.0523076923077,127.70153846153846,120.35076923076923,{"y":113,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":99.773,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":100.785,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.436,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":129.519,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":131.389,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":141.85,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":132.79,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":128.05,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":134.41,"date":1777593600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":164.13,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":183.19,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":203.66,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":208.56,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$235.00

Average Price Target$197.44

Lowest Price Target$113.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Eve Burstein

Bernstein

$215

Hold

-4.50%

Downside

Reiterated

09/09/26

Bernstein Reaffirms Their Hold Rating on Illumina (ILMN)

Jasper Hellweg

Argus Research

$180→$235

Buy

4.38%

Upside

Reiterated

09/02/26

Illumina price target raised to $235 from $180 at ArgusIllumina price target raised to $235 from $180 at Argus

Dan Leonard

RBC Capital

$230

Buy

2.16%

Upside

Reiterated

08/10/26

Analysts Are Bullish on Top Healthcare Stocks: Jazz Pharmaceuticals (JAZZ), Surgery Partners (SGRY)

Michael Ryskin

Bank of America Securities

$140

Sell

-37.82%

Downside

Reiterated

08/05/26

Illumina: One-Time Consumables Boost Masks Weak Underlying Demand; Sell Rating Reiterated with Unchanged $140 Price Target

Ilya Zubkov

Freedom Capital Markets

$155→$185

Hold

-17.83%

Downside

Downgraded

08/05/26

Illumina downgraded to Hold from Buy at Freedom BrokerIllumina downgraded to Hold from Buy at Freedom Broker

Daniel Arias

Stifel Nicolaus

$225

Buy

-0.06%

Downside

Reiterated

08/04/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Casey Woodring

J.P. Morgan

$230

Buy

2.16%

Upside

Reiterated

08/04/26

J.P. Morgan Keeps Their Buy Rating on Illumina (ILMN)

David Westenberg

Piper Sandler

$200→$225

Buy

-0.06%

Downside

Reiterated

08/03/26

Analysts Offer Insights on Healthcare Companies: Illumina (NASDAQ: ILMN) and InspireMD (NASDAQ: NSPR)

Kyle Mikson CFA

Canaccord Genuity

$190→$205

Hold

-8.95%

Downside

Reiterated

08/03/26

Canaccord Genuity Remains a Hold on Illumina (ILMN)

Patrick B Donnelly

Citi

$95→$113

Sell

-49.81%

Downside

Reiterated

08/03/26

Illumina price target raised to $113 from $95 at CitiIllumina price target raised to $113 from $95 at Citi

Daniel Brennan

TD Cowen

$192→$210

Hold

-6.72%

Downside

Assigned

07/31/26

TD Cowen Keeps Their Hold Rating on Illumina (ILMN)

Luke Sergott

Barclays

$145→$160

Sell

-28.93%

Downside

Reiterated

07/31/26

Barclays Sticks to Its Sell Rating for Illumina (ILMN)

Subbu Nambi

Guggenheim

$200→$226

Buy

0.38%

Upside

Reiterated

07/30/26

Illumina price target raised to $226 from $200 at GuggenheimIllumina price target raised to $226 from $200 at Guggenheim

Puneet Souda

Leerink Partners

$175→$210

Buy

-6.72%

Downside

Reiterated

07/17/26

Analysts' Top Healthcare Picks: Insmed (INSM), Illumina (ILMN)

Vijay Kumar

Evercore ISI

$155→$200

Buy

-11.17%

Downside

Reiterated

07/06/26

Illumina price target raised to $200 from $155 at Evercore ISIIllumina price target raised to $200 from $155 at Evercore ISI

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Eve Burstein

Bernstein

$215

Hold

-4.50%

Downside

Reiterated

09/09/26

Bernstein Reaffirms Their Hold Rating on Illumina (ILMN)

Jasper Hellweg

Argus Research

$180→$235

Buy

4.38%

Upside

Reiterated

09/02/26

Illumina price target raised to $235 from $180 at ArgusIllumina price target raised to $235 from $180 at Argus

Dan Leonard

RBC Capital

$230

Buy

2.16%

Upside

Reiterated

08/10/26

Analysts Are Bullish on Top Healthcare Stocks: Jazz Pharmaceuticals (JAZZ), Surgery Partners (SGRY)

Michael Ryskin

Bank of America Securities

$140

Sell

-37.82%

Downside

Reiterated

08/05/26

Illumina: One-Time Consumables Boost Masks Weak Underlying Demand; Sell Rating Reiterated with Unchanged $140 Price Target

Ilya Zubkov

Freedom Capital Markets

$155→$185

Hold

-17.83%

Downside

Downgraded

08/05/26

Illumina downgraded to Hold from Buy at Freedom BrokerIllumina downgraded to Hold from Buy at Freedom Broker

Daniel Arias

Stifel Nicolaus

$225

Buy

-0.06%

Downside

Reiterated

08/04/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Casey Woodring

J.P. Morgan

$230

Buy

2.16%

Upside

Reiterated

08/04/26

J.P. Morgan Keeps Their Buy Rating on Illumina (ILMN)

David Westenberg

Piper Sandler

$200→$225

Buy

-0.06%

Downside

Reiterated

08/03/26

Analysts Offer Insights on Healthcare Companies: Illumina (NASDAQ: ILMN) and InspireMD (NASDAQ: NSPR)

Kyle Mikson CFA

Canaccord Genuity

$190→$205

Hold

-8.95%

Downside

Reiterated

08/03/26

Canaccord Genuity Remains a Hold on Illumina (ILMN)

Patrick B Donnelly

Citi

$95→$113

Sell

-49.81%

Downside

Reiterated

08/03/26

Illumina price target raised to $113 from $95 at CitiIllumina price target raised to $113 from $95 at Citi

Daniel Brennan

TD Cowen

$192→$210

Hold

-6.72%

Downside

Assigned

07/31/26

TD Cowen Keeps Their Hold Rating on Illumina (ILMN)

Luke Sergott

Barclays

$145→$160

Sell

-28.93%

Downside

Reiterated

07/31/26

Barclays Sticks to Its Sell Rating for Illumina (ILMN)

Subbu Nambi

Guggenheim

$200→$226

Buy

0.38%

Upside

Reiterated

07/30/26

Illumina price target raised to $226 from $200 at GuggenheimIllumina price target raised to $226 from $200 at Guggenheim

Puneet Souda

Leerink Partners

$175→$210

Buy

-6.72%

Downside

Reiterated

07/17/26

Analysts' Top Healthcare Picks: Insmed (INSM), Illumina (ILMN)

Vijay Kumar

Evercore ISI

$155→$200

Buy

-11.17%

Downside

Reiterated

07/06/26

Illumina price target raised to $200 from $155 at Evercore ISIIllumina price target raised to $200 from $155 at Evercore ISI

Stocks with the Highest Top Analyst Consensus in the General Sector

STDNStandard Nuclear

SKHYSK Hynix

ITGITG Inc. Class A

LIMENeutron Holdings, Inc.

EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Illumina

3 Months

Patrick B DonnellyCiti

Success Rate

10/17 ratings generated profit

Average Return

-0.79%

Copying Patrick B Donnelly's trades and holding each position for 3 Months would result in 58.82% of your transactions generating a profit, with an average return of -0.79% per trade.

1 Year

Dan LeonardRBC Capital

Success Rate

10/16 ratings generated profit

Average Return

+9.18%

Copying Dan Leonard's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of +9.18% per trade.

2 Years

Dan LeonardRBC Capital

Success Rate

11/16 ratings generated profit

Average Return

+13.48%

Copying Dan Leonard's trades and holding each position for 2 Years would result in 68.75% of your transactions generating a profit, with an average return of +13.48% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0J8Z Analyst Recommendation Trends

Rating

May 26

Jun 26

Jul 26

Aug 26

Sep 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0J8Z has received 13 Buy Ratings, 9 Hold Ratings, and 4 Sell Ratings. 0J8Z average Analyst price target in the past 3 months is 197.44.

Each month's total comprises the sum of three months' worth of ratings.

0J8Z Financial Forecast

0J8Z Earnings Forecast

Next quarter’s earnings estimate for 0J8Z is $1.36 with a range of $1.33 to $1.38. The previous quarter’s EPS was $1.31. 0J8Z beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year 0J8Z has Performed in-line its overall industry.

0J8Z Sales Forecast

Next quarter’s sales forecast for 0J8Z is $1.15B with a range of $1.14B to $1.16B. The previous quarter’s sales results were $1.16B. 0J8Z beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year 0J8Z has Performed in-line its overall industry.

0J8Z Stock Forecast FAQ

What is GB:0J8Z’s average 12-month price target, according to analysts?

Based on analyst ratings, Illumina’s 12-month average price target is 197.44.

What is GB:0J8Z’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for GB:0J8Z, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Illumina a Buy, Sell or Hold?

Illumina has a consensus rating of Moderate Buy, which is based on 8 buy ratings, 5 hold ratings and 3 sell ratings.

What is Illumina’s share price target?

The average share price target for Illumina is 197.44. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $235.00 ,and the lowest forecast is $113.00. The average share price target represents -12.30% Decrease from the current price of $225.14.

What do analysts say about Illumina?

Illumina’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 16 Wall Streets Analysts.

How can I buy shares of Illumina?

To buy shares of GB:0J8Z, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Illumina (0J8Z) Share Forecast & Price Target

0J8Z Analyst Ratings

0J8Z Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Illumina

0J8Z Analyst Recommendation Trends

0J8Z Financial Forecast

0J8Z Earnings Forecast

0J8Z Sales Forecast

0J8Z Stock Forecast FAQ

Detailed List of Analyst Forecasts